Top Markets
Coin of the day
AegirBio AB (publ) AegirBio AB (publ)

AegirBio AB (publ)

AEGIR
Clasificación en acciones #38667
AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden.... AegirBio AB (publ) is a diagnostics firm established in 2019 in Lund, Sweden. The company specializes in developing and commercializing tests primarily aimed at monitoring the dosage of biological drugs. Their efforts are concentrated on therapeutic drug monitoring for biologic therapies across various conditions, including multiple sclerosis, different types of cancer, and autoimmune diseases. Among their offerings are moNATor, a pioneering laboratory test designed for dose monitoring in multiple sclerosis for both medical professionals and patients, and Viraspec, a saliva-based test kit for COVID-19 detection.
Precio por acción
$0.04057595
Última sincronización: 2024-08-05
Capitalización bursátil
$863.62K
Cambio (1 día)
0.31%
Cambio (1 año)
0.00%
País
SE
Comercio AegirBio AB (publ) (AEGIR)

Categoría

Ratio P/S de AegirBio AB (publ) (AEGIR)
Ratio P/S al August 2026 TTM: 167.72
Según los informes financieros más recientes y el precio de las acciones de AegirBio AB (publ), el ratio P/S actual (TTM) es 167.72. Al final de 2022, el ratio P/S era 22.63.
Historial del ratio P/S de AegirBio AB (publ) desde 2019 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
2026 (TTM) 167.72 -47.36%
2023 318.62 1,307.72%
2022 22.63 -67.86%
2021 70.42 0.00%
2020 0.00 0.00%
2019 0.00 0.00%
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
11.31 -93.26%
US
2.57 -98.46%
FR
- -
JP
2.81 -98.33%
US
- -
CH